Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI
暂无分享,去创建一个
Wen Cheng | Ming Yang | Yue Zhang | Wenlu Zhao | Han Wang | Shengren Guo | Wen-lu Zhao | Ming Yang | Yue Zhang | Wen Cheng | H. Wang | Sheng-Wen Guo
[1] S. Kumano,et al. Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging. , 2012, European journal of radiology.
[2] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[3] L. V. van Vliet,et al. Comparison between dynamic gadoxetate-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function , 2019, European Radiology.
[4] T. Sone,et al. Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers. , 2011, European journal of radiology.
[5] U. Motosugi,et al. Liver parenchymal enhancement of hepatocyte‐phase images in Gd‐EOB‐DTPA‐enhanced MR imaging: Which biological markers of the liver function affect the enhancement? , 2009, Journal of magnetic resonance imaging : JMRI.
[6] T. Miyati,et al. A novel method for evaluating enhancement using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid in the hepatobiliary phase of magnetic resonance imaging. , 2016, Clinical imaging.
[7] P. Meier,et al. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. , 1999, The Journal of pharmacology and experimental therapeutics.
[8] T. Nakayama,et al. Liver analysis using gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging: Correlation with histological grading and quantitative liver evaluation prior to hepatectomy , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.
[9] J. Ledsam,et al. Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention , 2013, European Radiology.
[10] S. Kumano,et al. Estimation of Liver Function Using T1 Mapping on Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging , 2011, Investigative radiology.
[11] A. Teufel,et al. Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation , 2015, Scientific Reports.
[12] T. Frenzel,et al. Mechanism of hepatic uptake of gadoxetate disodium. , 1996, Academic radiology.
[13] F. Wacker,et al. Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC) , 2016, European Radiology.
[14] J. Kao,et al. Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients , 2011, European Radiology.
[15] D. Seehofer,et al. Imaging-based evaluation of liver function: comparison of 99mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRI , 2015, European Radiology.
[16] T. Nagao,et al. Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule. , 2011, World journal of gastroenterology.
[17] J. Lodge. Assessment of hepatic reserve for the indication of hepatic resection: how I do it. , 2005, Journal of hepato-biliary-pancreatic surgery.
[18] H. Weinmann,et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. , 1992, Radiology.
[19] V. Chernyak,et al. Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: associated clinical and imaging factors. , 2015, Clinical radiology.
[20] O. Matsui,et al. Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma. , 2012, European journal of radiology.
[21] K. Bae,et al. Biliary tract enhancement in gadoxetic acid-enhanced MRI correlates with liver function biomarkers. , 2016, European journal of radiology.
[22] 坪山 尚寛. Hepatocellular carcinoma : hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging : correlation with expression of sinusoidal and canalicular transporters and bile accumulation , 2012 .
[23] T. Utsunomiya,et al. Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve , 2012, Journal of Gastroenterology.
[24] H. Hussain,et al. Primovist, Eovist: what to expect? , 2012, Journal of hepatology.
[25] Po-Huang Lee,et al. Use of indocyanine green for functional assessment of human hepatocytes for transplantation. , 2012, Asian journal of surgery.
[26] B. Hamm,et al. Imaging-Based Liver Function Tests – Past, Present and Future , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
[27] Tae Un Kim,et al. Significance of the “Delayed hyperintense portal vein sign” in the hepatobiliary phase MRI obtained with Gd‐EOB‐DTPA , 2012, Journal of magnetic resonance imaging : JMRI.
[28] T. Tamada,et al. Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis. , 2012, Magnetic resonance imaging.
[29] M. Filauro,et al. Assessment of hepatic reserve for the indication of hepatic resection: how I do it. , 2005, Journal of hepato-biliary-pancreatic surgery.
[30] P. Sandström,et al. Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study , 2012, European Radiology.
[31] J. Han,et al. Quantitative Liver Function Analysis: Volumetric T1 Mapping with Fast Multisection B1 Inhomogeneity Correction in Hepatocyte-specific Contrast-enhanced Liver MR Imaging. , 2017, Radiology.
[32] J. Veniero,et al. Focal liver lesion detection and characterization with GD-EOB-DTPA. , 2011, Clinical radiology.
[33] Chunhong Hu,et al. Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla , 2018, Abdominal Radiology.
[34] E. Gabazza,et al. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance , 2000, Journal of Gastroenterology.